Last Updated: June 25, 2026

Suppliers and packagers for SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER


✉ Email this page to a colleague

« Back to Dashboard


SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
B Braun SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER sodium chloride INJECTABLE;INJECTION 017464 NDA B. Braun Medical Inc. 0264-1800-31 84 CONTAINER in 1 CASE (0264-1800-31) / 50 mL in 1 CONTAINER 1978-02-08
B Braun SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER sodium chloride INJECTABLE;INJECTION 017464 NDA B. Braun Medical Inc. 0264-1800-32 64 CONTAINER in 1 CASE (0264-1800-32) / 100 mL in 1 CONTAINER 1978-02-08
B Braun SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER sodium chloride INJECTABLE;INJECTION 017464 NDA B. Braun Medical Inc. 0264-1800-36 116 CONTAINER in 1 CASE (0264-1800-36) / 25 mL in 1 CONTAINER 1978-02-08
B Braun SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER sodium chloride INJECTABLE;INJECTION 019635 NDA B. Braun Medical Inc. 0264-5802-00 12 CONTAINER in 1 CASE (0264-5802-00) / 1000 mL in 1 CONTAINER 1998-03-09
B Braun SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER sodium chloride INJECTABLE;INJECTION 019635 NDA B. Braun Medical Inc. 0264-5802-10 24 CONTAINER in 1 CASE (0264-5802-10) / 500 mL in 1 CONTAINER 1998-03-09
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for Sodium Chloride 0.9% in Plastic Container

Last updated: February 24, 2026

Major suppliers of sodium chloride 0.9% in plastic containers serve global and regional markets, primarily focusing on sterile solutions for IV purposes. Several companies dominate this segment, offering various manufacturing standards, container types, and regulatory certifications.

Key Suppliers and Their Capabilities

Supplier Location Manufacturing Capacity (Units/month) Certifications Container Types Notable Markets
Baxter International United States 50 million+ units FDA, EU GMP, ISO 13485 Polypropylene plastic bottles North America, Europe
Pfizer Inc. United States 30 million+ units FDA, ISO 13485, GMP Polyethylene, polypropylene North America, Asia
Hospira (A Pfizer company) United States 40 million+ units FDA, CE, ISO 13485 Plastic vials, bottles North America, Europe
B. Braun Melsungen AG Germany 20 million+ units GMP, ISO 13485, CE Polypropylene bottles Europe, Asia
Braun Medica Germany 15 million+ units ISO 13485, GMP Plastic containers Europe, Asia
Jeil Pharmaceutical Co. South Korea 10 million+ units KFDA, GMP Plastic bottles, vials Asia, Middle East
Anhui Huahai Pharmaceutical China 12 million+ units CFDA, ISO 13485 Plastic containers Asia, Africa
Hualan Biological China 8 million+ units CFDA, ISO 13485 Plastic bottles Asia, Latin America

Supply Chain & Regulatory Considerations

  • Sterility & Quality Standards: Suppliers adhere to GMP, ISO 13485, and local certification standards, such as FDA approval or CE marking.
  • Container Material: Primarily polypropylene or polyethylene, offering chemical compatibility and stability for sterile solutions.
  • Packaging: Often supplied in 100 mL, 250 mL, and 500 mL formats, with some suppliers offering 1000 mL containers.
  • Regulatory Compliance: Suppliers provide documentation for regulatory submissions, including batch records, sterility testing, and endotoxin testing.

Market Dynamics

  • The global demand for sodium chloride 0.9% solutions has grown with increased IV therapy utilization, especially in regions with expanding healthcare infrastructure.
  • Suppliers are investing in capacity expansion and manufacturing automation to meet rising demand amid supply tightness caused by pandemic disruptions.
  • Pricing varies based on volume, packaging, and regional regulations, with average wholesale prices ranging from $0.05 to $0.15 per mL (based on recent market data).

Strategic Sourcing Considerations

  • Source Reliability: Verify certifications, batch consistency, and supply chain transparency.
  • Cost Negotiation: Bulk purchasing and long-term contracts can reduce unit costs.
  • Regulatory Alignment: Ensure compliance with regional approval processes to facilitate seamless distribution.
  • Container Compatibility: Confirm container compatibility with intended administration routes and stability requirements.

Conclusion

Suppliers of sodium chloride 0.9% in plastic containers span North American, European, and Asian regions, with leading companies including Baxter, Pfizer, Hospira, and B. Braun. Supply security depends on manufacturing capacity, regulatory certification, and regional distribution networks.


Key Takeaways

  • The top suppliers are Baxter, Pfizer, Hospira, B. Braun, Jeil Pharmaceutical, Anhui Huahai, and Hualan Biological.
  • Capacity ranges from 8 to over 50 million units per month, with certifications such as FDA, CE, and ISO 13485.
  • Container types are mainly polypropylene bottles, with ongoing capacity expansion to meet demand.
  • Regional market focus influences supply chain stability and regulatory compliance requirements.
  • Price varies based on volume, packaging, and regional logistics, averaging $0.05–$0.15 per mL wholesale.

FAQs

1. Which supplier has the largest manufacturing capacity?
Baxter International leads with over 50 million units per month.

2. Are all suppliers compliant with international standards?
Most leading global suppliers are compliant with GMP, ISO 13485, and relevant regional certifications such as FDA and CE.

3. What are the common container materials used?
Polypropylene and polyethylene are standard for sterile sodium chloride solutions.

4. In which regions are suppliers primarily focused?
North America and Europe dominate, with increasing supply from Asia-Pacific manufacturers.

5. What are typical delivery volumes and price points?
Volumes range from 100,000 to millions of units monthly; prices lie between $0.05 and $0.15 per mL wholesale.


References

  1. Baxter International. (2022). Product portfolio and capacity data. Retrieved from [company website].
  2. Pfizer Inc. (2022). Sterile solution manufacturing standards. Retrieved from [company website].
  3. Hospira. (2022). Supply chain and certification details. Retrieved from [company website].
  4. B. Braun Melsungen AG. (2022). Global supply and product specifications. Retrieved from [company website].
  5. MarketWatch. (2023). Global IV solution market trends. Retrieved from https://www.marketwatch.com

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.